Financial Projections - The estimated net profit for 2024 is projected to be between 50 million and 60 million RMB, representing a year-on-year growth of 42.89% to 71.46% compared to 34.99 million RMB in the previous year[3]. - The estimated net profit after deducting non-recurring gains and losses is projected to be between 49.75 million and 59.75 million RMB, indicating a year-on-year growth of 47.09% to 76.65% compared to 33.82 million RMB in the previous year[3]. - The basic earnings per share are expected to be between 0.22 RMB and 0.26 RMB, up from 0.15 RMB in the previous year[3]. - The financial data presented is preliminary and has not been audited by the accounting firm, with final figures to be disclosed in the annual report[5]. Business Strategy - The company is focusing on expanding its market presence in food, pharmaceuticals, and high-end industrial sectors, while enhancing strategic partnerships with core customers[4]. - The company is increasing its R&D investment to continuously develop new products, particularly in the oral care business[4]. - The company is optimizing its product structure and improving product quality to meet diverse market demands[4].
金三江(301059) - 2024 Q4 - 年度业绩预告